Literature DB >> 6830179

Recurrent herpes simplex encephalitis: recovery of virus after Ara-A treatment.

R D Dix, J R Baringer, H S Panitch, S H Rosenberg, J Hagedorn, J Whaley.   

Abstract

A 54-year-old man developed clinical findings consistent with herpes simplex virus (HSV) encephalitis. These signs included an abrupt onset of focal central nervous system disease, cerebrospinal fluid pleocytosis, localized electroencephalographic abnormalities, and a computerized tomographic scan showing right temporal lobe involvement. Treatment with adenine arabinoside (Ara-A) resulted in improvement. Two months later he again became confused, and a left hemiparesis developed. Although biopsy revealed extensive necrosis and inflammatory response, HSV antigens and herpesvirus particles were not detected. Culture of biopsy tissue yielded HSV type 1 only after 18 days. A second course of Ara-A was administered but the patient failed to improve and died four months later. Extensive inflammatory necrosis of both temporal lobes involving gray and white matter was found. Cultures were negative for HSV. The recovery of virus from our patient during the second encephalitic episode should raise concerns regarding the efficacy of Ara-A treatment and the role of the virus in recurrent disease. In addition, the importance of maintaining biopsy tissue in culture for prolonged periods is emphasized.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6830179     DOI: 10.1002/ana.410130216

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

1.  Subacute herpes simplex encephalitis presenting as relapsing encephalitis.

Authors:  Nils Peters; Gunther Fesl; Diethilde Theil; Ulrich Schüller; Tobias Birnbaum; Hartmut Brückmann; Soheyl Noachtar
Journal:  J Neurol       Date:  2010-01-23       Impact factor: 4.849

2.  Herpes simplex encephalitis with relapse.

Authors:  M G Pike; C R Kennedy; B G Neville; M Levin
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

Review 3.  Herpes simplex virus infections of the central nervous system. Encephalitis and neonatal herpes.

Authors:  R J Whitley
Journal:  Drugs       Date:  1991-09       Impact factor: 9.546

4.  Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice.

Authors:  R D Dix; R R McKendall; J R Baringer
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

5.  Intravenous infusion of cereport increases uptake and efficacy of acyclovir in herpes simplex virus-infected rat brains.

Authors:  D J Bidanset; L Placidi; R Rybak; J Palmer; J P Sommadossi; E R Kern
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

6.  Incidence and pathogenesis of clinical relapse after herpes simplex encephalitis in adults.

Authors:  B Sköldenberg; E Aurelius; A Hjalmarsson; F Sabri; M Forsgren; B Andersson; A Linde; O Strannegård; M Studahl; L Hagberg; L Rosengren
Journal:  J Neurol       Date:  2005-10-17       Impact factor: 4.849

7.  Retropharyngeal abscess.

Authors:  M Coulthard; D Isaacs
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

8.  Relapse of herpes simplex encephalitis after acyclovir therapy.

Authors:  P Nicolaidou; N Iacovidou; S Youroukos; T Liacopoulou-Tsitsipi; C Kattamis
Journal:  Eur J Pediatr       Date:  1993-09       Impact factor: 3.183

9.  Acyclovir treatment of herpes simplex encephalitis: experience in a district hospital.

Authors:  M C Gulliford; C P Chandrasekera; R A Cooper; R P Murphy
Journal:  Postgrad Med J       Date:  1987-12       Impact factor: 2.401

10.  Clinical Neuropathology practice guide 4-2013: post-herpes simplex encephalitis: N-methyl-Daspartate receptor antibodies are part of the problem.

Authors:  Romana Höftberger; Thaís Armangue; Frank Leypoldt; Francesc Graus; Josep Dalmau
Journal:  Clin Neuropathol       Date:  2013 Jul-Aug       Impact factor: 1.368

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.